Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia

Journal of Molecular Diagnostics - United States
doi 10.2353/jmoldx.2009.080095
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia

Cancer Research
Cancer ResearchOncology
2004English

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

Haematologica
Hematology
2015English

Re-Evaluating the Role of BCR/ABL in Chronic Myelogenous Leukemia

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2014English

Inhibitory Effects of Omacetaxine on Leukemic Stem Cells and BCR-ABL-induced Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Mice

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Arginine Butyrate Downregulates P210 BCR-Abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1998English

Denovo BCR-ABL Positive Acute Myelogenous Leukemia in Adult Saudi Patient-A Case Report

Journal of Cancer Prevention & Current Research
2017English

Acute Myeloid Leukemia With BCR/ABL Fusion Chimera

Indian Journal of Hematology and Blood Transfusion
Hematology
2014English

Nilotinib Treatment in Mouse Models of P190 BCR/Abl Lymphoblastic Leukemia

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2007English

Alternative TEL-JAK2 Fusions Associated With T-Cell Acute Lymphoblastic Leukemia and Atypical Chronic Myelogenous Leukemia Dissected in Zebrafish

Haematologica
Hematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy